Skip to main content
Premium Trial:

Request an Annual Quote

Tm Biosciences Receives US, Canadian Standards Certifications for Genetic Tests

NEW YORK, Nov. 3 (GenomeWeb News) - Tm Bioscience of Toronto has received a certification that its processes meet standards for both US and Canadian medical device standards, the company said today.


The company's quality management system has been certified to both the ISO 13485:1996 standard and the requirements of the Canadian Medical Devices Conformity Assessment System, the company said. The certificate covers processes for development, manufacture, and distribution of genetic tests for mutations in the areas of hematology, cystic fibrosis, toxicology, and other areas, as well as analyte specific reagents, in vitro diagnostic medical devices, and software used to test for genetic mutations, according to Tm.


Tm launched its P450 2D6 test in June.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.